-
Nov 21, 2012 10:27AM
Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded
-
May 1, 2012 03:58PM
Baird Maintains a 'Neutral' on Biogen (BIIB); Still Prefer the Sidelines as Pipeline Remains The Focus
-
Apr 19, 2012 12:17PM
Streetinsider.com's Hot Lunchtime Reads 04/19: (SINA) (BIIB) (NFLX) (BAC) (SVVC)
-
Apr 19, 2012 10:38AM
Baird Maintains a 'Neutral' on Biogen (NASDAQ: BIIB); Raising Estimates Ahead of Earnings
-
Jan 31, 2012 04:07PM
Baird Reiterates a 'Neutral' on Biogen (BIIB); Conservative FY12 Guidance - However Still All About Pipeline
-
Oct 26, 2011 01:31PM
Baird Maintains a 'Neutral' on Biogen (BIIB); CONFIRM Hits; BG12 Approvable; Commercial Uptake the Next Question
-
Sep 13, 2011 08:43AM
Baird Maintains a 'Neutral' on Biogen (BIIB); Hemophilia Update Moderately Incremental; Still All About BG-12
-
Aug 1, 2011 02:57PM
Baird Maintains Acorda Therapeutics (ACOR) Neutral Rating, Says Takeout Still Seems Best Option
-
Jul 12, 2011 09:55AM
Baird maintains a 'Neutral' on Acorda Therapeutics (ACOR); BIIB Takeout Makes Sense, But Commercial Headwinds Exist
-
Apr 25, 2011 10:41AM
Notable Analyst Rating Changes 04/25: (TZOO) (BIIB) (GE) Upgraded; (VECO) (SLM) (NUE) Downgraded
-
Feb 28, 2011 07:43AM
Baird Maintains Neutral Rating on Biogen (BIIB), Gilenya Losing Momentum
-
Sep 22, 2010 10:39AM
Baird reiterates a 'Neutral' on Back Biogen Idec Inc. (BIIB); Gilenya Hits the Market; Advise a Bit of Caution Here
-
Apr 20, 2010 02:59PM
Baird Maintains Neutral Stance on Biogen Idec (BIIB) After Q1 Results
-
Oct 23, 2009 10:36AM
Elan (ELN) and Biogen (BIIB) Weak On Jump In Tysabri PML Cases
-
Sep 4, 2009 09:26AM
Morning Movers 9/4: EXXI, LTXC, FNM, MTXX, FRE Higher; ARRY, ZQK, ELN Lower
-
Aug 26, 2009 10:48AM
Notable Analyst Rating Changes 8/26: STJ, GMR, KMT, CP Upgraded; BKC, AMED, MDAS Downgraded
-
Feb 6, 2009 09:41AM
Notable Analyst Rating Changes 2/6: UL, TLB, COST, FLIR Upgraded; ABMD, BIIB, ESLR, BKC, MET Downgraded
-
Feb 6, 2009 09:32AM
Baird Downgrades Biogen Idec (BIIB) On Tysabri, Not Buying Takeover Talk
-
Jan 23, 2009 09:30AM
Baird Said Buy Biogen Idec (BIIB) On Any PFE/WYE Merger Talk Weakness
-
Nov 3, 2008 09:53AM
Notable Analyst Rating Changes 11/03: WMT, BIIB, NVDA, SLB Upgraded; SSCC, DO, HAL, PHM Downgraded
-
Nov 3, 2008 09:36AM
Morning Movers 11/03: VeraSun (VSE) Sinks On Bankrupcty; Goodyear (GT) and Oshkosh (OSK) Up On Results
-
Nov 3, 2008 07:18AM
Baird Upgrades Biogen Idec (BIIB) to Outperform
-
Aug 1, 2008 11:30AM
Biogen Idec (BIIB) Sinks on TYSABRI PML Fears, Wall Street Comments...
-
Aug 1, 2008 07:28AM
Biogen (BIIB) volatility Flat; shares down on Tysabri link to brain infection
-
Jul 21, 2008 09:21AM
Pre-Open Movers 7/21: Genentech (DNA) Higher on Bid for Roche; BofA (BAC) Up on Results
-
Jan 15, 2008 11:13AM
Notable Analyst Rating Changes 1/15: STO, NOC, BIIB Upgraded; BP, SLB, GRMN, HAR Downgraded